Athletic Injuries

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

IBSA Institut Biochimique
IBSA Institut BiochimiqueSwitzerland - Lugano-Pazzallo
1 program
1
Diclofenac hydroxyethylpyrrolidinePhase 41 trial
Active Trials
NCT02132247CompletedEst. May 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
IBSA Institut BiochimiqueDiclofenac hydroxyethylpyrrolidine

Clinical Trials (1)

NCT02132247IBSA Institut BiochimiqueDiclofenac hydroxyethylpyrrolidine

Safety Study of Flector Patch in Children With Minor Soft Tissue Injuries

Start: May 2014Est. completion: May 2017
Phase 4Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space